ERIS Lifesciences consolidated net profit rises 52.94% in the September 2026 quarter

Sales rise 12.57% to Rs 889.50 crore

Net profit of ERIS Lifesciences rose 52.94% to Rs 183.82 crore in the quarter ended September 2026 as against Rs 120.19 crore during the previous quarter ended September 2025. Sales rose 12.57% to Rs 889.50 crore in the quarter ended September 2026 as against Rs 790.15 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	889.50	790.15	13
OPM %	34.68	36.48	-
PBDT	265.23	241.75	10
PBT	191.81	172.67	11
NP	183.82	120.19	53

Powered by Capital Market - Live News